Dayzerodiagnostics
1 known investors
The page is a bioMérieux blog article about tracking a Cyclospora cayetanensis outbreak in the United States, referencing its clinical diagnostic and wastewater surveillance products for community health and medical professionals.
BiotechDigital HealthMedical Devices
Investors · 1
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $303.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Dayzerodiagnostics do?
- The page is a bioMérieux blog article about tracking a Cyclospora cayetanensis outbreak in the United States, referencing its clinical diagnostic and wastewater surveillance products for community health and medical professionals.
- Who are Dayzerodiagnostics's investors?
- Dayzerodiagnostics's investors include Triventures.